Best Practice & Research Clinical Rheumatology
Volume 20, Issue 5 , Pages 969-981, October 2006

The role of mesenchymal cells in the pathophysiology of inflammatory arthritis

  • Lars-Henrik Meyer, MSc (Research Fellow)
  • ,
  • Lars Franssen, MSc (Research Fellow)
  • ,
  • Thomas Pap, MD (Professor of Experimental Medicine and Head)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +49 251 835 7798; Fax: +49 251 835 7462.

Division of Molecular Medicine of Musculoskeletal Tissue, Department of Orthopedics, University Hospital Muenster, Domagkstrasse 3, D-48149 Munster, Germany

Rheumatoid arthritis (RA) is a chronic inflammatory disorder of the joints that can cause severe disability. While the role of inflammatory cells in the pathogenesis of RA has been well established, the specific contribution of resident cells within the synovial membrane, especially those of mesenchymal origin, has become the object of closer scrutiny only recently. The central position of these cells in the disease process of RA is underlined by their involvement in its main pathophysiological features: inflammation, hyperplasia and joint destruction. In this chapter, we provide a characterisation of resident mesenchymal cells, specifically fibroblast-like cells in the rheumatoid synovium, and give an overview of the molecular pathways by which these cells are involved in the initiation and perpetuation of RA.

Key words: fibroblast-like synoviocytes, hyperplasia, apoptosis, Fas, activation, attachment, extracellular matrix degradation, matrix metalloproteinases

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6942(06)00077-5

doi:10.1016/j.berh.2006.06.005

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 5 , Pages 969-981, October 2006